| scholarly article | Q13442814 |
| P50 | author | Carol Tamminga | Q29904486 |
| Deborah R. Medoff | Q109579239 | ||
| P2093 | author name string | Carpenter WT Jr | |
| Holcomb HH | |||
| Lahti AC | |||
| Weiler MA | |||
| P433 | issue | 11 | |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | schizophrenia | Q41112 |
| P1104 | number of pages | 12 | |
| P304 | page(s) | 1797-1808 | |
| P577 | publication date | 2001-11-01 | |
| P1433 | published in | American Journal of Psychiatry | Q1935368 |
| P1476 | title | Abnormal patterns of regional cerebral blood flow in schizophrenia with primary negative symptoms during an effortful auditory recognition task | |
| P478 | volume | 158 |
| Q38559235 | Avolition, Negative Symptoms, and a Clinical Science Journey and Transition to the Future. |
| Q91676610 | Cerebral blood flow in striatal regions is associated with apathy in patients with schizophrenia |
| Q37412196 | Connectivity, pharmacology, and computation: toward a mechanistic understanding of neural system dysfunction in schizophrenia |
| Q48016632 | Convergence and Divergence of Brain Network Dysfunction in Deficit and Non-deficit Schizophrenia |
| Q53572453 | Correlations between rCBF and symptoms in two independent cohorts of drug-free patients with schizophrenia. |
| Q35818882 | Cortical structural abnormalities in deficit versus nondeficit schizophrenia |
| Q60959871 | DNA Methylation and Gene Expression of Matrix Metalloproteinase 9 Gene in Deficit and Non-deficit Schizophrenia |
| Q50464912 | Deficit of pericapillary oligodendrocytes in the prefrontal cortex in schizophrenia. |
| Q37287211 | Deficit schizophrenia: an update |
| Q37075844 | Deficit schizophrenia: association with serum antibodies to cytomegalovirus |
| Q34869701 | Early-course unmedicated schizophrenia patients exhibit elevated prefrontal connectivity associated with longitudinal change |
| Q44902190 | Efficacy of bilateral repetitive transcranial magnetic stimulation for negative symptoms of schizophrenia: results of a multicenter double-blind randomized controlled trial |
| Q50716056 | Executive functioning and psychopathological profile in relatives of individuals with deficit v. non-deficit schizophrenia: a pilot study. |
| Q44388433 | Frontal lesions do not alter the differential extinction of taste aversion conditioning in rats, when using two methods of sucrose delivery |
| Q58758788 | Human Endogenous Retroviral Envelope Protein Syncytin-1 and Inflammatory Abnormalities in Neuropsychological Diseases |
| Q48684926 | Hypofrontality in schizophrenic patients and its relevance for the choice of antipsychotic medication: an event-related potential study |
| Q36870045 | Inflammation and schizophrenia |
| Q38281866 | Mirror neuron dysfunction in schizophrenia and its functional implications: a systematic review. |
| Q50700399 | Multi-components of evoked-brain potentials in deficit and nondeficit schizophrenia. |
| Q30913824 | Neurobiological background of negative symptoms |
| Q35779544 | Neurocognitive Impairments in Deficit and Non-Deficit Schizophrenia and Their Relationships with Symptom Dimensions and Other Clinical Variables |
| Q48076142 | Neurocognitive impairment in the deficit subtype of schizophrenia |
| Q30573043 | Neuroimaging studies in schizophrenia: an overview of research from Asia |
| Q41600823 | Neuropsychological Profile of Specific Executive Dysfunctions in Patients with Deficit and Non-deficit Schizophrenia |
| Q31084441 | Neuropsychology of the deficit syndrome: new data and meta-analysis of findings to date |
| Q33950864 | Olfactory hedonic judgment in patients with deficit syndrome schizophrenia |
| Q33438218 | Prefrontal activation deficits during episodic memory in schizophrenia |
| Q33824821 | Reduced anterior cingulate gray matter volume and thickness in subjects with deficit schizophrenia |
| Q34356672 | Resting neural activity distinguishes subgroups of schizophrenia patients |
| Q33989669 | Resting quantitative cerebral blood flow in schizophrenia measured by pulsed arterial spin labeling perfusion MRI. |
| Q37825634 | Revisiting the diagnosis of schizophrenia: where have we been and where are we going? |
| Q39731696 | Striatal function in relation to negative symptoms in schizophrenia. |
| Q48344527 | The effects of clozapine on cognitive function and regional cerebral blood flow in the negative symptom profile schizophrenia |
| Q39177258 | The effects of olanzapine treatment on brain regional glucose metabolism in neuroleptic-naive first-episode schizophrenic patients. |
| Q37075795 | The factorial structure of the schedule for the deficit syndrome in schizophrenia |
| Q30477381 | The functional neuroanatomy of symptom dimensions in schizophrenia: a qualitative and quantitative review of a persistent question. |
| Q34612231 | The interplay between mitochondrial complex I, dopamine and Sp1 in schizophrenia |
| Q24800460 | Theories of schizophrenia: a genetic-inflammatory-vascular synthesis |
| Q34578532 | Weakened center-surround interactions in visual motion processing in schizophrenia. |
| Q37159928 | White matter alterations in deficit schizophrenia. |
| Q45015941 | White matter alterations in schizophrenic patients with pronounced negative symptomatology and with positive family history for schizophrenia |
Search more.